56 related articles for article (PubMed ID: 32500478)
21. Advances in exploring activity cliffs.
Stumpfe D; Hu H; Bajorath J
J Comput Aided Mol Des; 2020 Sep; 34(9):929-942. PubMed ID: 32367387
[TBL] [Abstract][Full Text] [Related]
22. Activity cliff networks for medicinal chemistry.
Stumpfe D; Bajorath J
Drug Dev Res; 2014 Aug; 75(5):291-8. PubMed ID: 25160069
[TBL] [Abstract][Full Text] [Related]
23. Computational method for the identification of third generation activity cliffs.
Stumpfe D; Hu H; Bajorath J
MethodsX; 2020; 7():100793. PubMed ID: 31993342
[TBL] [Abstract][Full Text] [Related]
24. Evolving Concept of Activity Cliffs.
Stumpfe D; Hu H; Bajorath J
ACS Omega; 2019 Sep; 4(11):14360-14368. PubMed ID: 31528788
[TBL] [Abstract][Full Text] [Related]
25. Extraction of SAR information from activity cliff clusters via matching molecular series.
Dimova D; Bajorath J
Eur J Med Chem; 2014 Nov; 87():454-60. PubMed ID: 25282268
[TBL] [Abstract][Full Text] [Related]
26. Method for the evaluation of structure-activity relationship information associated with coordinated activity cliffs.
Dimova D; Stumpfe D; Bajorath J
J Med Chem; 2014 Aug; 57(15):6553-63. PubMed ID: 25014781
[TBL] [Abstract][Full Text] [Related]
27. Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?
Cruz-Monteagudo M; Medina-Franco JL; Pérez-Castillo Y; Nicolotti O; Cordeiro MN; Borges F
Drug Discov Today; 2014 Aug; 19(8):1069-80. PubMed ID: 24560935
[TBL] [Abstract][Full Text] [Related]
28. Composition and topology of activity cliff clusters formed by bioactive compounds.
Stumpfe D; Dimova D; Bajorath J
J Chem Inf Model; 2014 Feb; 54(2):451-61. PubMed ID: 24437577
[TBL] [Abstract][Full Text] [Related]
29. Molecular similarity in medicinal chemistry.
Maggiora G; Vogt M; Stumpfe D; Bajorath J
J Med Chem; 2014 Apr; 57(8):3186-204. PubMed ID: 24151987
[TBL] [Abstract][Full Text] [Related]
30. Recent progress in understanding activity cliffs and their utility in medicinal chemistry.
Stumpfe D; Hu Y; Dimova D; Bajorath J
J Med Chem; 2014 Jan; 57(1):18-28. PubMed ID: 23981118
[TBL] [Abstract][Full Text] [Related]
31. Activity cliffs: facts or artifacts?
Medina-Franco JL
Chem Biol Drug Des; 2013 May; 81(5):553-6. PubMed ID: 23375049
[TBL] [Abstract][Full Text] [Related]
32. MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs.
Hu X; Hu Y; Vogt M; Stumpfe D; Bajorath J
J Chem Inf Model; 2012 May; 52(5):1138-45. PubMed ID: 22489665
[TBL] [Abstract][Full Text] [Related]
33. Exploring activity cliffs in medicinal chemistry.
Stumpfe D; Bajorath J
J Med Chem; 2012 Apr; 55(7):2932-42. PubMed ID: 22236250
[No Abstract] [Full Text] [Related]
34. ChEMBL: a large-scale bioactivity database for drug discovery.
Gaulton A; Bellis LJ; Bento AP; Chambers J; Davies M; Hersey A; Light Y; McGlinchey S; Michalovich D; Al-Lazikani B; Overington JP
Nucleic Acids Res; 2012 Jan; 40(Database issue):D1100-7. PubMed ID: 21948594
[TBL] [Abstract][Full Text] [Related]
35. Local structural changes, global data views: graphical substructure-activity relationship trailing.
Wawer M; Bajorath J
J Med Chem; 2011 Apr; 54(8):2944-51. PubMed ID: 21443196
[TBL] [Abstract][Full Text] [Related]
36. Cytoscape 2.8: new features for data integration and network visualization.
Smoot ME; Ono K; Ruscheinski J; Wang PL; Ideker T
Bioinformatics; 2011 Feb; 27(3):431-2. PubMed ID: 21149340
[TBL] [Abstract][Full Text] [Related]
37. Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets.
Hussain J; Rea C
J Chem Inf Model; 2010 Mar; 50(3):339-48. PubMed ID: 20121045
[TBL] [Abstract][Full Text] [Related]
38. On outliers and activity cliffs--why QSAR often disappoints.
Maggiora GM
J Chem Inf Model; 2006; 46(4):1535. PubMed ID: 16859285
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
